CEREBROVASCULAR DISORDERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND RESISTANT HYPERTENSION

被引:0
|
作者
Falkovskaya, Alla Yu [1 ]
Mordovin, Victor F. [1 ]
Sukhareva, Anna E. [1 ]
Zyubanova, Irina, V [1 ]
Manukyan, Musheg A. [1 ]
Lichikaki, Valeriya A. [1 ]
Tsoi, Ekaterina, I [1 ]
Gusakova, Anna M. [1 ]
Dorozhkina, Natalya, V [1 ]
机构
[1] Russian Acad Sci, Tomsk Natl Res Med Ctr, Cardiol Res Inst, Tomsk, Russia
来源
DIABETES MELLITUS | 2022年 / 25卷 / 02期
关键词
diabetes mellitus; resistant hypertension; brain MRI; cerebrovascular disease; cytokines; adipokines; vasoreactivity; DISEASE; RISK; PREVALENCE;
D O I
10.14341/DM12779
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Diabetes mellitus (DM) and hypertension are risk factors for cerebral stroke, which are exacerbated by the combination of these diseases. Identifying the factors involved in the development of subclinical brain damage could change the therapeutic strategy for protecting the brain. AIM: to study severity of MRI- sings of brain damage and to identify factors associated with their development in patients with type 2 diabetes and RHTN. MATERIALS AND METHODS: 46 patients with type 2 DM and RHTN were included in a single-center observational uncontrolled study. Patients underwent brain MRI (1.5 Tesla) with calculation of Evans's index (EI), clinical and lab examinations (HbA 1c, glucose, insulin, C-peptide, leptin, resistin, TNF- a, hsCRP, blood aldosterone, insulin-like growth factor-1 (IGF-1)), measurement of the office and ambulatory blood pressure (BP), assessment of peripheral and cerebral vasoreactivity (test with hyperventilation and breath holding). RESULTS: The most frequent MR brain changes were white matter lesions ( WML) in periventricular region (PVR) (89%), focal WML (52%) and expansion both of the ventricles (45%) and subarachnoid spaces (65%). Multiple direct correlations were revealed between parameters of carbohydrate metabolism with the degree of WML in PVR and the density of the MR-signal in the basal nucleus (BN), as well as with EI. Adipokines had a direct relationship with the size of the chiasmatic cistern and IE (for resistin), as well as with the density of the MR signal from the BN and IE (for leptin), that was also directly related to the IGF-1 level. The aldosterone level positively correlated with the size of III ventricle. An increase in TNF-a and hsCRP was accompanied by an increase in the density of the MR-signal in the PVR. Impairment of cerebrovascular reactivity is associated with an increase in the density of the MR-signal in PVR and with indirect signs of cerebral atrophy (increase in EI, the size of cisterns and lateral ventricles). Impairment of peripheral vasoreactivity had direct relationship with EI and the expansion of the III ventricle. There were no direct correlations between the severity of MR-sings of brain damage and BP levels. CONCLUSION: The combination of type 2 DM with RHTN is characterized by a high frequency of WML and liquorodynamics disturbances, which related with metabolic, neurohormonal and hemodynamic factors in the absence of a direct relationship with the degree of BP increase.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [31] Prevalence of hypertension and obesity in patients with type 2 Diabetes Mellitus
    Cruz, Misma Silva
    Ferreira da Silva, Ingrid Cristina
    Goncalves Miguez, Jessica Silva
    Rocha Machado, Mariana Pirani
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [32] Treatment of hypertension in patients with type-2 diabetes mellitus
    Kjeldsen, SE
    Os, I
    Farsang, C
    Mallion, JM
    Hansson, L
    Sleight, P
    JOURNAL OF HYPERTENSION, 2000, 18 (09) : 1345 - 1346
  • [33] MRI OF THE ARTERIAL WALL IN RESISTANT HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS
    Ryumshina, Nadezhda, I
    Falkovskaya, Alla Y.
    Gusakova, Anna M.
    Mordovin, Victor F.
    Usov, Vladimir Y.
    DIABETES MELLITUS, 2020, 23 (01): : 29 - 36
  • [34] Resistant Hypertension Prevalence in Type 2 Diabetes Mellitus: Relationship to Renal Function
    Weinrauch, Larry A.
    Segal, Alissa
    Wisniewski, Eric
    D'Elia, John A.
    DIABETES, 2015, 64 : A615 - A615
  • [35] LEPTIN AS A PREDICTOR OF CARDIOPROTECTIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Manukyan, Musheg
    Falkovskaya, Alla
    Mordovin, Victor
    Zyubanova, Irina
    Tsoy, Ekaterina
    Pekarskiy, Stanislav
    Ryabova, Tamara
    Khunkhinova, Simzhit
    Vtorushina, Anastasia
    Gusakova, Anna
    Suslova, Tatiana
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E244 - E244
  • [36] THE EFFECT OF RENAL DENERVATION ON PERIPHERAL AND CEREBRAL VASOREACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, Alla
    Mordovin, V.
    Pekarskiy, S.
    Manukyan, M.
    Zyubanova, I.
    Lichikaki, V.
    Tsoy, E.
    Vtorushina, A.
    Khunkhinova, S.
    Shalishev, I.
    Triss, S.
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E244 - E244
  • [37] Refractory and resistant hypertension in patients with type 2 diabetes mellitus: differences in metabolic profile and endothelial function
    Falkovskaya, A. Yu
    Mordovin, V. F.
    Pekarskiy, S. E.
    Ripp, T. M.
    Manukyan, M. A.
    Lichikaki, V. A.
    Zyubanova, I., V
    Sitkova, E. S.
    Gusakova, A. M.
    Ryabova, T. R.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (01) : 49 - 58
  • [38] DYNAMICS OF GLYCEMIC CONTROL AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Falkovskaya, A. Yu.
    Mordovin, V. F.
    Pekarsky, S. Ye.
    Bayev, A. Ye.
    Semke, G. V.
    Ripp, T. M.
    Kravtchenko, Ye. S.
    Zyubanova, I. V.
    BYULLETEN SIBIRSKOY MEDITSINY, 2015, 14 (05): : 83 - 90
  • [39] Update on Hypertension Management: Treatment of hypertension in patients with type 2 diabetes mellitus
    Nilsson, PM
    Cifkova, R
    Kjeldsen, SE
    JOURNAL OF HYPERTENSION, 2006, 24 (01) : 208 - 210
  • [40] Resistant Hypertension in Diabetes Mellitus
    Bayliss, George
    Weinrauch, Larry A.
    D'Elia, John A.
    CURRENT DIABETES REPORTS, 2014, 14 (08)